抗精神病药对通道的直接影响
Wenwen Zhuang1, Seo-Yeong Mun1, Won Sun Park1
1Department of Physiology, Kangwon National University School of Medicine, Chuncheon, 24341, South Korea.
Biochemical and biophysical research communications
|January 22, 2025
概括
用于精神分裂症和双相情感障碍的抗精神病药物可以通过影响 (K +) 通道引起副作用. 本综述探讨了这些对各种器官的非目标效应.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生化学
背景情况:
- 精神分裂症 (SCZ) 和双相情感障碍 (BD) 是主要的精神疾病,具有重大的全球健康和经济影响.
- 目前的抗精神病治疗虽然有效,但与许多副作用有关.
- 许多抗精神病药物与 (K+) 通道相互作用,影响各种生理功能.
研究的目的:
- 审查抗精神病药物的生物作用.
- 为了阐明与 (K+) 通道相互作用相关的抗精神病药物的非目标副作用.
主要方法:
- 对抗精神病机制现有研究的文献综述.
- 对抗精神病药物对各种K+通道亚型 (Kv,KCa,Kir,K2P) 的影响的研究分析.
主要成果:
- 抗精神病药物表现出超出其主要治疗点的一系列生物作用.
- 与K+通道的非目标相互作用是抗精神病副作用的常见机制.
- 这些通道相互作用可以导致多个器官系统的功能变化.
结论:
- 了解抗精神病药对K+通道的影响对于预测和管理副作用至关重要.
- 对K+通道调节的进一步研究可能会导致开发更安全,更有效的抗精神病疗法.
相关概念视频
Antihypertensive Drugs: Potassium-Sparing Diuretics
442
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
442
Antiepileptic Drugs: Potassium Channel Activators
142
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
142
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
895
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
895
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K
Antipsychotic Drugs: Typical and Atypical Agents
151
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
151
Antiepileptic Drugs: Calcium Channel Blockers
299
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
299


